Wells Fargo & Company Evotec Se Transaction History

Wells Fargo & Company

  • $434 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
BUY
$10.78 - $15.5 $16,169 - $23,250
1,500 Added 37.5%
5,500 $66,000
Q1 2022

May 16, 2022
BUY
$12.93 - $23.46 $38,764 - $70,333
2,998 Added 299.2%
4,000 $61,000
Q4 2021

Feb 14, 2022
BUY
$22.0 - $25.77 $22,044 - $25,821
1,002 New
1,002 $24,000

Others Institutions Holding EVO

# of Institutions
25
Shares Held
3.42M
Call Options Held
0
Put Options Held
0
View Full List

About Evotec SE

EVO Quotes by TradingView
  • Ticker EVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 353,904,992
  • Market Cap $1.58B
  • Description
  • Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare di...
More about EVO
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email